melatonin has been researched along with Multiple Sclerosis, Chronic Progressive in 2 studies
Multiple Sclerosis, Chronic Progressive: A form of multiple sclerosis characterized by a progressive deterioration in neurologic function which is in contrast to the more typical relapsing remitting form. If the clinical course is free of distinct remissions, it is referred to as primary progressive multiple sclerosis. When the progressive decline is punctuated by acute exacerbations, it is referred to as progressive relapsing multiple sclerosis. The term secondary progressive multiple sclerosis is used when relapsing remitting multiple sclerosis evolves into the chronic progressive form. (From Ann Neurol 1994;36 Suppl:S73-S79; Adams et al., Principles of Neurology, 6th ed, pp903-914)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin was her only treatment for the next 4 years; during this interval, her EDSS progressively recovered to 6." | 5.42 | Melatonin treatment improves primary progressive multiple sclerosis: a case report. ( Álvarez-Sánchez, N; Carrillo-Vico, A; Cruz-Chamorro, I; Guerrero, JM; Lardone, PJ; López-González, A; Martínez-López, A; Reiter, RJ, 2015) |
| "Melatonin was her only treatment for the next 4 years; during this interval, her EDSS progressively recovered to 6." | 1.42 | Melatonin treatment improves primary progressive multiple sclerosis: a case report. ( Álvarez-Sánchez, N; Carrillo-Vico, A; Cruz-Chamorro, I; Guerrero, JM; Lardone, PJ; López-González, A; Martínez-López, A; Reiter, RJ, 2015) |
| "Melatonin is a potent neuroprotectant." | 1.39 | Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course. ( Kędziora, J; Majsterek, I; Miller, E; Walczak, A, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, E | 1 |
| Walczak, A | 1 |
| Majsterek, I | 1 |
| Kędziora, J | 1 |
| López-González, A | 1 |
| Álvarez-Sánchez, N | 1 |
| Lardone, PJ | 1 |
| Cruz-Chamorro, I | 1 |
| Martínez-López, A | 1 |
| Guerrero, JM | 1 |
| Reiter, RJ | 1 |
| Carrillo-Vico, A | 1 |
2 other studies available for melatonin and Multiple Sclerosis, Chronic Progressive
| Article | Year |
|---|---|
Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course.
Topics: Adult; Erythrocytes; Female; Humans; Male; Melatonin; Middle Aged; Multiple Sclerosis, Chronic Progr | 2013 |
Melatonin treatment improves primary progressive multiple sclerosis: a case report.
Topics: Adult; Female; Humans; Melatonin; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive | 2015 |